Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Azathioprine
Drug ID BADD_D00195
Description Azathioprine is a prodrug of 6-mercaptopurine, first synthesized in 1956 by Gertrude Elion, William Lange, and George Hitchings in an attempt to produce a derivative of 6-mercaptopurine with a better therapeutic index.[A189678,A189687,A189690] Azathioprine is used to treat inflammatory conditions like rheumatoid arthritis and as an immunosuppressant in the prevention of renal transplant rejection.[L11214] Azathiprine was granted FDA approval on 20 March 1968.[L11214]
Indications and Usage Anstey A, Lear JT: Azathioprine: clinical pharmacology and current indications in autoimmune disorders. BioDrugs. 1998 Jan;9(1):33-47.
Marketing Status Prescription; Discontinued
ATC Code L04AX01
DrugBank ID DB00993
KEGG ID D00238
MeSH ID D001379
PubChem ID 2265
TTD Drug ID D07QCE
NDC Product Code 72789-129; 51407-182; 46014-1110; 62991-2189; 12780-0300; 51927-2258; 48954-909; 51552-0779; 15308-0732; 42973-143; 68382-120; 38779-0312; 68382-119; 67877-492; 70771-1139; 65649-241; 68382-118; 67877-494; 54766-590; 68462-502; 0378-1005; 71610-124; 60219-2036; 70771-1140; 51927-0071; 65841-602; 68382-003; 71610-306; 42291-071; 60219-2037; 68084-229; 60219-1076; 70771-1141; 49452-0783; 65649-231; 67877-495; 67877-493; 66122-0009
Synonyms Azathioprine | Azothioprine | Imurel | Imuran | Immuran | Azathioprine Sodium | Sodium, Azathioprine | Azathioprine Sodium Salt | Azathioprine Sulfate
Chemical Information
Molecular Formula C9H7N7O2S
CAS Registry Number 446-86-6
SMILES CN1C=NC(=C1SC2=NC=NC3=C2NC=N3)[N+](=O)[O-]
Chemical Structure
ADR Related Proteins Induced by Drug
ADR Term Protein Name UniProt AC TTD Target ID PMID
Adverse drug reactionThiopurine S-methyltransferaseP51580Not Available15228171; 9893619; 12525681; 7818564; 7979599; 9778228; 8984938; 12429535; 7774088; 12509611; 14505127
Adverse drug reactionInosine triphosphate pyrophosphataseQ9BY32Not Available15167706; 15571265; 15973722
Adverse drug reactionThiopurine S-methyltransferaseP51580Not Available10461478; 12021625; 14566029; 8738760; 12021625
Bone marrow toxicityThiopurine S-methyltransferaseP51580Not Available15228171; 9893619; 12525681; 7818564; 7979599; 9778228; 8984938; 12429535; 7774088; 12509611; 14505127
Bone marrow toxicityCytosolic 5'-nucleotidase 1AQ9BXI3Not Available7818564; 7979599; 9778228; 8984938; 12429535; 7774088; 12509611; 14505127
Bone marrow toxicityPurine nucleoside phosphorylaseP00491T781987818564; 7979599; 9778228; 8984938; 12429535; 7774088; 12509611; 14505127
Bone marrow toxicityThiopurine S-methyltransferaseP51580Not Available10461478; 12021625; 14566029; 8738760; 12021625
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Hepatotoxicity12.03.01.008; 09.01.07.0090.009334%Not Available
Hernia08.01.04.0010.001436%Not Available
Herpes simplex23.09.03.001; 11.05.02.0010.004308%Not Available
Herpes virus infection11.05.02.0080.002872%Not Available
Herpes zoster23.09.03.002; 11.05.02.0030.007898%
Hidradenitis23.02.03.0130.003590%Not Available
Histoplasmosis11.03.06.0010.002154%Not Available
Hodgkin's disease01.16.01.001; 16.31.01.0010.000937%Not Available
Hodgkin's disease lymphocyte depletion type stage unspecified16.31.03.001; 01.16.03.001--Not Available
Hodgkin's disease lymphocyte predominance type stage unspecified01.16.04.001; 16.31.04.001--Not Available
Humerus fracture15.08.03.008; 12.04.01.0090.001436%Not Available
Hydrops foetalis18.03.02.0080.004308%Not Available
Hyperhidrosis23.02.03.004; 08.01.03.028--
Hyperkalaemia14.05.03.001--
Hyperkeratosis23.01.01.0010.002154%
Hyperlactacidaemia14.01.01.0060.002154%Not Available
Hypersensitivity10.01.03.0030.020822%
Hypersensitivity vasculitis10.02.02.017; 01.01.04.008; 24.05.02.012; 23.06.02.0050.002872%Not Available
Hypertension24.08.02.001--
Hypoaesthesia17.02.06.0230.011488%Not Available
Hypoalbuminaemia14.10.01.002; 09.01.02.0030.003590%
Hypocalcaemia14.04.01.0040.002872%
Hypogammaglobulinaemia10.03.01.0010.001436%Not Available
Hypokalaemia14.05.03.0020.004308%
Hypoproteinaemia14.10.01.003; 09.01.02.0040.001436%Not Available
Hypotension24.06.03.002--
Hypothyroidism14.11.01.012; 05.02.03.001--
Hypoxia22.02.02.0030.004308%
IIIrd nerve paralysis17.04.02.003; 06.05.02.0110.001436%Not Available
Ileal perforation07.04.06.0100.002154%
The 9th Page    First    Pre   9 10 11 12 13    Next   Last    Total 27 Pages